Pharma Technology Investment Trends - Head of Diagnostics, Top 15 Pharma

As part of an interview campaign to understand how pharma invests in technology supporting the development of precision medicines, we interviewed a head of diagnostics at a top 15 pharma company.
Publish Date
February 28, 2023
Category
Transcripts
Price
$ 700.00 USD
Publish Date
February 28, 2023
Category
Transcripts
Price
$ 700.00 USD
Publish Date
February 28, 2023
Category
Transcripts
Price
$ 700.00 USD
No items found.

The head of diagnostics at a major pharmaceutical company speaks to how their company prioritizes investments today, how they experience ROI, and how broader oncology trends will impact spending in the next 3 – 5 years. This expert is involved in decision making for a variety of funding initiatives, including data purchases or the implementation of biomarkers and clinical trials, though they are not directly playing a role in the R&D budget. They see the most investment today in the research tools setting, which is where they also feel that they experience in the most ROI. In addition to established tools like genomics and liquid biopsy, they see a fair share of investment in imaging as well, and in other areas such as clinical trial operations and real-world data. Though not receiving the dominant share of spending today, bioinformatics and companion diagnostics are two other areas that this expert sees strong ROI in the form of streamlining development of efficacious products. They note that they are still cautious about in vitro disease models. When asked about pain points, this expert noted that they feel that the U.S. healthcare system creates some barriers, including issues to data access for patients and properly promoting testing. Broadly, they expect that trends towards earlier cancer detection, more targeted treatments, and emerging treatment modalities will be important considerations for future investments.

Summary Report
PDF deck with summarized feedback from stakeholders
Interview Transcripts
Individual PDFs of call transcripts with stakeholders
Report + Transcript Bundle
This package includes both the PDF deck and transcripts, providing a comprehensive understanding of stakeholders' views. You will receive a summarized report in the form of a PDF deck, as well as the full transcript of the discussions.
Price
$ 700.00 USD
To claim your free report, simply fill out the form below with your contact information, and we’ll send it to you right away. Don’t miss out on this opportunity to gain a competitive edge in your industry. Sign up now!
Request Access
Summary Report
PDF deck with summarized feedback from stakeholders
Interview Transcripts
Individual PDFs of call transcripts with stakeholders
Report + Transcript Bundle
This package includes both the PDF deck and transcripts, providing a comprehensive understanding of stakeholders' views. You will receive a summarized report in the form of a PDF deck, as well as the full transcript of the discussions.
Price
$ 700.00 USD
Price
$ 700.00 USD
Summary Report
PDF deck with summarized feedback from stakeholders
Interview Transcripts
Individual PDFs of call transcripts with stakeholders
Report + Transcript Bundle
This package includes both the PDF deck and transcripts, providing a comprehensive understanding of stakeholders' views. You will receive a summarized report in the form of a PDF deck, as well as the full transcript of the discussions.
Price
$ 700.00 USD

Experience the DeciBio Difference

Engage with our experts at DeciBio to discover how our tailored solutions can meet your unique needs.
Request Demo Today

Experience the DeciBio Difference

Engage with our experts at DeciBio to discover how our tailored solutions can meet your unique needs.
Request Demo Today
Precision Medicine is evolving at a rapid pace

Discover how we can help

Get in Touch